Publication date: Sep 01, 2025
To assess physician practices, attitudes, and challenges related to pediatric COVID-19 vaccination in the United States. An online survey of 102 pediatricians and 104 family medicine physicians who serve pediatric patients in the United States was conducted during August 15-16, 2023, using an opt-in internet survey panel. The majority (86. 3%) of physicians reported that their office had ever offered COVID-19 vaccination, and among those that had ever offered it, 91. 7% reported currently offering it to some or all pediatric patients aged 6 months-17 years old. Slightly more than half (54. 8%) of physicians strongly agreed and 32. 0% agreed with the statement, “I believe COVID-19 vaccine is generally safe for children,” and about 84% strongly agreed or agreed that benefits of pediatric COVID-19 vaccination outweighed possible risks and side effects of the vaccine and inconveniences. The top 3 identified challenges of offering COVID-19 vaccination to pediatric patients were 1) lack of demand from parents (48. 8%), 2) different vaccine products/formulations for different age groups (37. 1%), and 3) large minimum package size/large number of doses per vial (32. 9%). Slightly more than 80% strongly agreed or agreed with the statement, “I believe that pharmacies can serve as an important place for COVID-19 vaccination of school-aged children. ” Most physicians reported offering the COVID-19 vaccine to their pediatric patients but reported that low parental demand posed challenges to achieving high pediatric COVID-19 vaccination coverage. Although physician confidence in COVID-19 vaccine safety was fairly high overall, improved confidence may increase the likelihood of a strong physician recommendation, leading to higher parental demand and uptake.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Inconveniences | family medicine physicians |
| Office | pediatric COVID-19 vaccination |
| Pediatricians | pediatricians |
| Vaccination |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |